MSB 2.17% $1.13 mesoblast limited

why mesoblast will drop substantially , page-10

  1. 80 Posts.
    lightbulb Created with Sketch. 3
    I'll have to re-read my technical analysis. It looks more look consolidation after a great run. Also reached new 12 month highs so I can't understand the head and shoulders breakdown. Also of note is the Teva/Cephalon deal itself. When a major pharmaceutical company with scientists a lot smarter than us put their hand in their kick to the tune of over $1B thru development to get a small piece of MSBs intellectual property they're not just punting on a penny dreadful. The Chines company Hanlong recently has bought ALL of Sundance recently for a similar figure. This is a tier 1 iron ore producer. So for similar amount a pharmaceutical company that would have done enormous due diligence has bought a much smaller amount in the feeling that the medical advancements proposed will be enormous.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.